FDA Adverse Event Injury Summary report: N

UNKNOWN KNEE TIBIAL INSERT

MDR report key: 7649867 · Received June 29, 2018

Report

Report Number
1818910-2018-63465
Event Type
Injury
Date Received
June 29, 2018
Date of Event
July 16, 2014
Report Date
June 6, 2018
Manufacturer
DEPUY IRELAND - 9616671
Product Code
JWH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
OTHER CAREGIVERS

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION SUMMARY: NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. DEPUY SYNTHES CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION MAY BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

MEDICAL RECORDS RECEIVED ON 06/06/2018. MEDICAL RECORDS REVIEWED FOR MDR REPORTABILITY. LEFT ATTUNE TOTAL KNEE REVISED TO ADDRESS POSSIBLE INFECTION. PATIENT TREATED BY INCISION AND DRAINAGE, REPAIR OF PARTIAL WOUND DEHISCENCE, AND EXCHANGE OF POLYETHYLENE TIBIAL INSERT. THERE WAS EVIDENCE OF SYNOVITIS. THE MEDICAL RECORDS CURRENTLY PROVIDE NO PRIMARY SURGERY INFORMATION OR PRODUCT LOT CODE INFORMATION. CEMENT MANUFACTURER FOR THE PRIMARY SURGERY IS ALSO UNKNOWN. AN ATTUNE INSERT WAS RE-IMPLANTED AT THE TIME OF REVISION, SUPPORTING THE ALLEGATION OF AN ATTUNE KNEE BEING PRESENT. DOI: UNKNOWN; DOR: (B)(6) 2014; (LEFT KNEE).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
493515 UNKNOWN KNEE TIBIAL INSERT KNEE TIBIAL INSERT JWH DEPUY IRELAND - 9616671

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention